A detailed history of Virtu Financial LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Virtu Financial LLC holds 4,212 shares of NBIX stock, worth $579,866. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,212
Holding current value
$579,866
% of portfolio
0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$130.4 - $143.74 $549,244 - $605,432
4,212 New
4,212 $581,000
Q2 2023

Jul 27, 2023

BUY
$89.53 - $104.87 $479,254 - $561,369
5,353 New
5,353 $505,000
Q3 2021

Nov 12, 2021

SELL
$86.18 - $99.03 $552,413 - $634,782
-6,410 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$89.43 - $102.27 $169,469 - $193,801
1,895 Added 41.97%
6,410 $624,000
Q1 2021

May 19, 2021

SELL
$87.57 - $119.4 $133,719 - $182,323
-1,527 Reduced 25.27%
4,515 $439,000
Q4 2020

Feb 24, 2021

SELL
$86.91 - $108.33 $1.21 Million - $1.5 Million
-13,877 Reduced 69.67%
6,042 $579,000
Q3 2020

Dec 11, 2020

BUY
$96.16 - $135.15 $1.31 Million - $1.85 Million
13,655 Added 217.99%
19,919 $1.92 Million
Q2 2020

Aug 07, 2020

BUY
$85.09 - $130.36 $533,003 - $816,575
6,264 New
6,264 $764,000
Q4 2019

Feb 04, 2020

SELL
$86.8 - $118.57 $407,526 - $556,686
-4,695 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$83.82 - $101.5 $393,534 - $476,542
4,695 New
4,695 $423,000
Q2 2019

Aug 13, 2019

SELL
$72.24 - $91.27 $665,402 - $840,687
-9,211 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$69.31 - $91.53 $638,414 - $843,082
9,211 New
9,211 $812,000
Q4 2018

Jan 16, 2019

SELL
$68.32 - $124.36 $281,068 - $511,617
-4,114 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$98.88 - $125.85 $406,792 - $517,746
4,114 New
4,114 $506,000
Q2 2018

Jul 30, 2018

SELL
$75.3 - $105.99 $549,012 - $772,773
-7,291 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$75.3 - $105.99 $636,285 - $895,615
-8,450 Reduced 53.68%
7,291 $716,000
Q1 2018

May 14, 2018

BUY
$75.88 - $92.43 $1.19 Million - $1.45 Million
15,741 New
15,741 $1.31 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.